Small EJ - Search Results

1

Prostate-specific antigen changes as surrogate for overall survival in men with metastatic castration-resistant prostate cancer treated with second-line chemotherapy.

Halabi S, Armstrong AJ, Sartor O, de Bono J, Kaplan E, Lin CY, Solomon NC, Small EJ. Halabi S, et al. Among authors: small ej. J Clin Oncol. 2013 Nov 1;31(31):3944-50. doi: 10.1200/JCO.2013.50.3201. Epub 2013 Oct 7. J Clin Oncol. 2013. PMID: 24101043 Free PMC article. Clinical Trial.

2

Prostate cancer: who to screen, and what the results mean.

Small EJ. Small EJ. Geriatrics. 1993 Dec;48(12):28-30, 35-8. Geriatrics. 1993. PMID: 7504646 Review.

3

Prostate-specific antigen decline after casodex withdrawal: evidence for an antiandrogen withdrawal syndrome.

Small EJ, Carroll PR. Small EJ, et al. Urology. 1994 Mar;43(3):408-10. doi: 10.1016/0090-4295(94)90092-2. Urology. 1994. PMID: 7510915

4

Malignant germ cell tumors in men infected with the human immunodeficiency virus: natural history and results of therapy.

Timmerman JM, Northfelt DW, Small EJ. Timmerman JM, et al. Among authors: small ej. J Clin Oncol. 1995 Jun;13(6):1391-7. doi: 10.1200/JCO.1995.13.6.1391. J Clin Oncol. 1995. PMID: 7538557

5

Doxorubicin and dose-escalated cyclophosphamide with granulocyte colony-stimulating factor for the treatment of hormone-resistant prostate cancer.

Small EJ, Srinivas S, Egan B, McMillan A, Rearden TP. Small EJ, et al. J Clin Oncol. 1996 May;14(5):1617-25. doi: 10.1200/JCO.1996.14.5.1617. J Clin Oncol. 1996. PMID: 8622080 Clinical Trial.

6

Second-line hormonal therapy for advanced prostate cancer: a shifting paradigm.

Small EJ, Vogelzang NJ. Small EJ, et al. J Clin Oncol. 1997 Jan;15(1):382-8. doi: 10.1200/JCO.1997.15.1.382. J Clin Oncol. 1997. PMID: 8996165 Review.

7

Prostate cancer.

Small EJ. Small EJ. Curr Opin Oncol. 1997 May;9(3):277-86. doi: 10.1097/00001622-199709030-00011. Curr Opin Oncol. 1997. PMID: 9229151 Review.

8

Update on the diagnosis and treatment of prostate cancer.

Small EJ. Small EJ. Curr Opin Oncol. 1998 May;10(3):244-52. doi: 10.1097/00001622-199805000-00012. Curr Opin Oncol. 1998. PMID: 9619361 Review.

9

Prostate cancer, Incidence, management and outcomes.

Small EJ. Small EJ. Drugs Aging. 1998 Jul;13(1):71-81. doi: 10.2165/00002512-199813010-00007. Drugs Aging. 1998. PMID: 9679210 Review.

10

Pyrazoloacridine for the treatment of hormone-refractory prostate cancer.

Small EJ, Fippin LJ, Whisenant SP. Small EJ, et al. Cancer Invest. 1998;16(7):456-61. doi: 10.3109/07357909809011699. Cancer Invest. 1998. PMID: 9774952 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

477 results

Search Page

Filters